These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Discussion on the monoamine oxidase inhibitors. Schiele BC Psychopharmacol Bull; 1986; 22(1):16-8. PubMed ID: 3726062 [No Abstract] [Full Text] [Related]
11. [Therapeutic indications of monoamine oxidase inhibitors]. Cervera Enguix S Rev Med Univ Navarra; 1991; 36(2):35-7. PubMed ID: 1792471 [No Abstract] [Full Text] [Related]
12. Problems with and promises of monoamine oxidase inhibitors. Klein DF; Quitkin FM Psychopharmacol Bull; 1986; 22(1):7-11. PubMed ID: 3726080 [No Abstract] [Full Text] [Related]
13. An overview of monoamine oxidase inhibitors. Introductory remarks. Burrows D J Neural Transm Suppl; 1989; 28():1-3. PubMed ID: 2677239 [No Abstract] [Full Text] [Related]
14. The pharmacology of reversible monoamine oxidase inhibitors. Amrein R; Allen SR; Guentert TW; Hartmann D; Lorscheid T; Schoerlin MP; Vranesic D Br J Psychiatry Suppl; 1989 Oct; (6):66-71. PubMed ID: 2695128 [TBL] [Abstract][Full Text] [Related]
15. MAO inhibitors in chronic pain and depression. Raskin DE J Clin Psychiatry; 1982 Mar; 43(3):122. PubMed ID: 7073869 [No Abstract] [Full Text] [Related]
16. [New perspectives on depression]. Gilaberte Asín I; Huete Muñoz T; Boto Maldonado B Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1994; 22(1):22-7. PubMed ID: 8209710 [TBL] [Abstract][Full Text] [Related]
17. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression]. Nolen WA Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774 [TBL] [Abstract][Full Text] [Related]